TCL Archive FDA Plans to Discuss the Negative Trial of AstraZeneca’s Drug Iressa With the Oncologic Drugs Advisory Committee in March. January 21, 2005
TCL Archive Research Program For Biological Response Modifiers Outlined By DCT board Subcommittee November 16, 1979